AlphaQuest LLC acquired a new position in Itron, Inc. (NASDAQ:ITRI - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,453 shares of the scientific and technical instruments company's stock, valued at approximately $466,000.
Several other institutional investors have also added to or reduced their stakes in ITRI. Janney Montgomery Scott LLC increased its stake in shares of Itron by 0.7% in the first quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company's stock worth $1,759,000 after purchasing an additional 121 shares in the last quarter. CoreCap Advisors LLC grew its stake in Itron by 25.5% in the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after buying an additional 125 shares in the last quarter. Captrust Financial Advisors grew its stake in Itron by 6.3% in the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock valued at $233,000 after buying an additional 128 shares in the last quarter. HighTower Advisors LLC raised its holdings in Itron by 2.0% during the 1st quarter. HighTower Advisors LLC now owns 7,501 shares of the scientific and technical instruments company's stock valued at $786,000 after acquiring an additional 146 shares during the period. Finally, Pinnacle Wealth Management Advisory Group LLC lifted its position in shares of Itron by 7.3% during the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company's stock worth $246,000 after acquiring an additional 160 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Itron
In other Itron news, CFO Joan S. Hooper sold 970 shares of the company's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the sale, the chief financial officer owned 88,394 shares of the company's stock, valued at $11,076,652.14. This represents a 1.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Donald L. Reeves III sold 547 shares of Itron stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $68,544.57. Following the transaction, the senior vice president directly owned 19,604 shares in the company, valued at $2,456,577.24. This trade represents a 2.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,856 shares of company stock worth $1,922,470. Company insiders own 1.51% of the company's stock.
Analysts Set New Price Targets
Several brokerages have recently weighed in on ITRI. Piper Sandler reduced their price target on Itron from $124.00 to $121.00 and set a "neutral" rating for the company in a research report on Monday, May 5th. JPMorgan Chase & Co. raised Itron from a "neutral" rating to an "overweight" rating and lifted their target price for the company from $128.00 to $145.00 in a report on Thursday, July 31st. Johnson Rice cut Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Roth Capital raised their price objective on shares of Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Finally, Stephens set a $130.00 price objective on shares of Itron in a research note on Monday, August 4th. Eleven equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $136.25.
Check Out Our Latest Research Report on Itron
Itron Price Performance
ITRI stock opened at $124.06 on Wednesday. The firm has a 50 day simple moving average of $130.54 and a two-hundred day simple moving average of $115.46. The stock has a market cap of $5.67 billion, a PE ratio of 21.21, a P/E/G ratio of 0.68 and a beta of 1.35. Itron, Inc. has a one year low of $90.11 and a one year high of $140.04. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75.
Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. The company had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm's revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.